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Background:  Fractional flow reserve (FFR), a physiological index of blood-flow reduction caused by coronary stenosis, has been 
shown by the FAME trials as a better predictor of clinical outcomes from revascularization than angiography alone. PET-derived absolute 
myocardial blood flow (MBF) and flow reserve (MFR) quantification have been shown to have added clinical value in detecting CAD. 
Currently, measurements of MBF and MFR are not lesion specific, calculated either globally for the entire LV, or regionally to pre-defined 
vascular or segmental territories. The aim of this work is to fuse information related to coronary anatomy from CT coronary angiography 
(CTA) and myocardial Rb82 or 13NH3 dynamic myocardial PET (dMPI) studies to explicitly combine anatomic and physiologic information 
to noninvasively measure absolute MBF, MFR and fractional flow reserve (FFR) across a specific coronary lesion.
methods:  30 patients (10 normal (NL), 20 LAD disease ≥ 50% stenosis) were used to establish proof-of-principle of our approach. 
Our HeartFusion 2G tool was used to fuse the 3D dMPI to the 3D CTA. Our FlowTool was used to measure MBF using established 
compartmental modeling with correction methodology including tracer extraction fraction. Mean NL ± 2 SD flow values as a function of 
vessel length (L) from proximal to distal (PtoD) were determined for the rest (r), and hyperemic stress (s) MBF(L) in the NL LADs positioned 
in the anterior interventricular groove. NL LAD MFR was also determined PtoD by averaging each NL LAD sMBF(L)/rMBF(L) ratio. PtoD 
FFR(L) was calculated as the ratio of each vessel’s sMBF(L) to mean NL sMBF(L). 
results:  Significant differences were found in sMBF (p<.001), MFR (p<.001) and FFR (p<.001) with increased values for NL vs. abnormal 
LADs but increased rMBF (p<.001) in abnormal LADs. When the individual flow measurements of each of the 20 diseased LAD vessels 
were compared to normal ranges, abnormalities were detected in sMBF (12/20), MFR (17*/20, *2 50% stenosis), FFR (16/20) and rMBF 
(0/20) at some point in the vessel. 
conclusion:  Our results show promise for the noninvasive quantification of MBF, MFR and myocardial FFR across specific coronary 
lesions from dynamic PET/CTA fused imagery. 
